Gastric Cancer Clinical Trials

There are 32 registered clinical trials for Gastric Cancer in the TrialLens index.

Trials (32)

Outcomes of Laparoscopic Gastrectomy N/A · Juan Carlos Martín del Olmo
Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer Phase 3 · Ukrainian Society of Clinical Oncology
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy N/A · University of Michigan Rogel Cancer Center
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis Phase 2 · University of California, Irvine
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma Phase 2/3 · Australasian Gastro-Intestinal Trials Group
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis Phase 2 · Sichuan University
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors Phase 1 · Sanofi
Nutrition Intervention Trials in Linxian Follow-up Study N/A · National Cancer Institute (NCI)
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) Phase 2 · I-Mab Biopharma US Limited
Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence Phase 3 · Jagiellonian University
Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer N/A · Second Affiliated Hospital, Zhejiang University, School of Medicine
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Phase 2 · Telix Pharmaceuticals (Innovations) Pty Ltd
SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer Phase 1/2 · West China Hospital
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer Phase 1/2 · Chongqing Precision Biotech Co., Ltd
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer Phase 3 · Fujian Medical University
Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy. N/A · Hospital Universitario La Fe
Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer N/A · D1 Medical Technology (Shanghai) Co., Ltd, China
Irinotecan in Treating Patients With Esophageal or Stomach Cancer Phase 2 · Jonsson Comprehensive Cancer Center
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy Phase 3 · Jiangsu HengRui Medicine Co., Ltd.
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 Phase 4 · University of Miami
New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy N/A · Shandong University
Safety and Efficacy of NK510 to Treat Gastric Cancer Early Phase 1 · Base Therapeutics (Shanghai) Co., Ltd.
Prehabilitation in Patients With Esophageal or Gastric Cancers N/A · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Domestic Surgical Robot Clinical Study N/A · The Third Xiangya Hospital of Central South University
Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers N/A · City of Hope Medical Center
WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy N/A · RenJi Hospital
Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction Phase 2 · Krankenhaus Nordwest
Myosteatosis in Oeso-gastric Cancer: Clinical Impacts N/A · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
EsophaCap for the Detection of Early Esophageal Carcinoma N/A · Johns Hopkins University
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study Phase 2 · Richard van Hillegersberg
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Phase 1 · Arcus Biosciences, Inc.
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer Phase 2 · Huashan Hospital

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.